Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Discover how a tiny RNA molecule serves as a molecular switch in viral infections, providing insights into phage biology.

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are looking to bacteriophages, viruses that infect bacteria, as an alternative.

Research revealed how bacteriophages use a tiny piece of genetic material to hijack bacterial cells and make more copies of themselves.

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are ...

Backed by a handful of prominent investors including the Gates Foundation, the startup is pursuing an approach it believes ...

A research group at the Italian Institute of Technology (Istituto Italiano di Tecnologia - IIT) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The ...